Benefit of pulmonary vein isolation guided by loss of pace capture on the ablation line: results from a prospective 2-center randomized trial

Standard

Benefit of pulmonary vein isolation guided by loss of pace capture on the ablation line: results from a prospective 2-center randomized trial. / Steven, Daniel; Sultan, Arian; Reddy, Vivek; Luker, Jakob; Altenburg, Manuel; Hoffmann, Boris; Rostock, Thomas; Servatius, Helge; Stevenson, William G; Willems, Stephan; Michaud, Gregory F.

in: J AM COLL CARDIOL, Jahrgang 62, Nr. 1, 02.07.2013, S. 44-50.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Steven, D, Sultan, A, Reddy, V, Luker, J, Altenburg, M, Hoffmann, B, Rostock, T, Servatius, H, Stevenson, WG, Willems, S & Michaud, GF 2013, 'Benefit of pulmonary vein isolation guided by loss of pace capture on the ablation line: results from a prospective 2-center randomized trial', J AM COLL CARDIOL, Jg. 62, Nr. 1, S. 44-50. https://doi.org/10.1016/j.jacc.2013.03.059

APA

Steven, D., Sultan, A., Reddy, V., Luker, J., Altenburg, M., Hoffmann, B., Rostock, T., Servatius, H., Stevenson, W. G., Willems, S., & Michaud, G. F. (2013). Benefit of pulmonary vein isolation guided by loss of pace capture on the ablation line: results from a prospective 2-center randomized trial. J AM COLL CARDIOL, 62(1), 44-50. https://doi.org/10.1016/j.jacc.2013.03.059

Vancouver

Bibtex

@article{84d0dd388c804fae9635a7c65bd46d44,
title = "Benefit of pulmonary vein isolation guided by loss of pace capture on the ablation line: results from a prospective 2-center randomized trial",
abstract = "OBJECTIVES: This study was conducted to determine if an additional procedural endpoint of unexcitability (UE) to pacing along the ablation line reduces recurrence of atrial fibrillation (AF) or atrial tachycardia (AT) after radiofrequency catheter ablation.BACKGROUND: AF/AT recurrence is common after pulmonary vein isolation (PVI).METHODS: We included 102 patients from 2 centers (age 63 ± 10 years; 33 women; left atrium 38 ± 7 mm; left ventricular ejection fraction 61 ± 6%) with symptomatic paroxysmal AF. A 3-dimensional mapping system and circumferential mapping catheter were used in all patients for PVI. In group 1 (n = 50), the procedural endpoint was bidirectional block across the ablation line. In group 2 (n = 52), additional UE to bipolar pacing at an output of 10 mA and 2-ms pulse width was required. The primary endpoint was freedom from any AF/AT (>30 s) after discontinuation of antiarrhythmic drugs.RESULTS: Procedural endpoints were successfully achieved in all patients. Procedure duration was significantly longer in group 2 (185 ± 58 min vs. 139 ± 57 min; p < 0.001); however, fluoroscopy times were not different (23 ± 9 min vs. 23 ± 9 min; p = 0.49). After a follow-up of 12 months in all patients, 26 patients (52%) in group 1 versus 43 (82.7%) in group 2 were free from any AF/AT (p = 0.001) after a single procedure. No major complications occurred.CONCLUSIONS: The use of pacing to ensure UE along the PVI line markedly improved near-term single-procedure success, compared with demonstration of bidirectional block alone. This additional endpoint significantly improved patient outcomes after PVI. (Unexcitability Along the Ablation as an Endpoint for Atrial Fibrillation Ablation; NCT01724437).",
keywords = "Aged, Atrial Fibrillation/diagnosis, Cardiac Pacing, Artificial/methods, Catheter Ablation/instrumentation, Female, Follow-Up Studies, Humans, Male, Middle Aged, Pilot Projects, Prospective Studies, Pulmonary Veins/physiology, Treatment Outcome",
author = "Daniel Steven and Arian Sultan and Vivek Reddy and Jakob Luker and Manuel Altenburg and Boris Hoffmann and Thomas Rostock and Helge Servatius and Stevenson, {William G} and Stephan Willems and Michaud, {Gregory F}",
note = "Copyright {\textcopyright} 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.",
year = "2013",
month = jul,
day = "2",
doi = "10.1016/j.jacc.2013.03.059",
language = "English",
volume = "62",
pages = "44--50",
journal = "J AM COLL CARDIOL",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "1",

}

RIS

TY - JOUR

T1 - Benefit of pulmonary vein isolation guided by loss of pace capture on the ablation line: results from a prospective 2-center randomized trial

AU - Steven, Daniel

AU - Sultan, Arian

AU - Reddy, Vivek

AU - Luker, Jakob

AU - Altenburg, Manuel

AU - Hoffmann, Boris

AU - Rostock, Thomas

AU - Servatius, Helge

AU - Stevenson, William G

AU - Willems, Stephan

AU - Michaud, Gregory F

N1 - Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

PY - 2013/7/2

Y1 - 2013/7/2

N2 - OBJECTIVES: This study was conducted to determine if an additional procedural endpoint of unexcitability (UE) to pacing along the ablation line reduces recurrence of atrial fibrillation (AF) or atrial tachycardia (AT) after radiofrequency catheter ablation.BACKGROUND: AF/AT recurrence is common after pulmonary vein isolation (PVI).METHODS: We included 102 patients from 2 centers (age 63 ± 10 years; 33 women; left atrium 38 ± 7 mm; left ventricular ejection fraction 61 ± 6%) with symptomatic paroxysmal AF. A 3-dimensional mapping system and circumferential mapping catheter were used in all patients for PVI. In group 1 (n = 50), the procedural endpoint was bidirectional block across the ablation line. In group 2 (n = 52), additional UE to bipolar pacing at an output of 10 mA and 2-ms pulse width was required. The primary endpoint was freedom from any AF/AT (>30 s) after discontinuation of antiarrhythmic drugs.RESULTS: Procedural endpoints were successfully achieved in all patients. Procedure duration was significantly longer in group 2 (185 ± 58 min vs. 139 ± 57 min; p < 0.001); however, fluoroscopy times were not different (23 ± 9 min vs. 23 ± 9 min; p = 0.49). After a follow-up of 12 months in all patients, 26 patients (52%) in group 1 versus 43 (82.7%) in group 2 were free from any AF/AT (p = 0.001) after a single procedure. No major complications occurred.CONCLUSIONS: The use of pacing to ensure UE along the PVI line markedly improved near-term single-procedure success, compared with demonstration of bidirectional block alone. This additional endpoint significantly improved patient outcomes after PVI. (Unexcitability Along the Ablation as an Endpoint for Atrial Fibrillation Ablation; NCT01724437).

AB - OBJECTIVES: This study was conducted to determine if an additional procedural endpoint of unexcitability (UE) to pacing along the ablation line reduces recurrence of atrial fibrillation (AF) or atrial tachycardia (AT) after radiofrequency catheter ablation.BACKGROUND: AF/AT recurrence is common after pulmonary vein isolation (PVI).METHODS: We included 102 patients from 2 centers (age 63 ± 10 years; 33 women; left atrium 38 ± 7 mm; left ventricular ejection fraction 61 ± 6%) with symptomatic paroxysmal AF. A 3-dimensional mapping system and circumferential mapping catheter were used in all patients for PVI. In group 1 (n = 50), the procedural endpoint was bidirectional block across the ablation line. In group 2 (n = 52), additional UE to bipolar pacing at an output of 10 mA and 2-ms pulse width was required. The primary endpoint was freedom from any AF/AT (>30 s) after discontinuation of antiarrhythmic drugs.RESULTS: Procedural endpoints were successfully achieved in all patients. Procedure duration was significantly longer in group 2 (185 ± 58 min vs. 139 ± 57 min; p < 0.001); however, fluoroscopy times were not different (23 ± 9 min vs. 23 ± 9 min; p = 0.49). After a follow-up of 12 months in all patients, 26 patients (52%) in group 1 versus 43 (82.7%) in group 2 were free from any AF/AT (p = 0.001) after a single procedure. No major complications occurred.CONCLUSIONS: The use of pacing to ensure UE along the PVI line markedly improved near-term single-procedure success, compared with demonstration of bidirectional block alone. This additional endpoint significantly improved patient outcomes after PVI. (Unexcitability Along the Ablation as an Endpoint for Atrial Fibrillation Ablation; NCT01724437).

KW - Aged

KW - Atrial Fibrillation/diagnosis

KW - Cardiac Pacing, Artificial/methods

KW - Catheter Ablation/instrumentation

KW - Female

KW - Follow-Up Studies

KW - Humans

KW - Male

KW - Middle Aged

KW - Pilot Projects

KW - Prospective Studies

KW - Pulmonary Veins/physiology

KW - Treatment Outcome

U2 - 10.1016/j.jacc.2013.03.059

DO - 10.1016/j.jacc.2013.03.059

M3 - SCORING: Journal article

C2 - 23644091

VL - 62

SP - 44

EP - 50

JO - J AM COLL CARDIOL

JF - J AM COLL CARDIOL

SN - 0735-1097

IS - 1

ER -